# Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium

> **NCT02094651** · PHASE2 · WITHDRAWN · sponsor: **Boston Children's Hospital**

## Conditions studied

- Autism

## Interventions

- **DRUG:** divalproex sodium
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02094651
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-04
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No eligible patients were enrolled
- **Last updated:** 2016-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02094651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02094651, "Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02094651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*